Status:
TERMINATED
Goal of Open Lung Ventilation in Donors
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
University of California, San Francisco
University of California, Los Angeles
Conditions:
Brain Death
Organ Donation
Eligibility:
All Genders
13+ years
Phase:
NA
Brief Summary
The primary goal of this study is to assess whether ventilation of deceased organ donors with an open lung protective ventilatory strategy will improve donor lung utilization rates and donor oxygenati...
Detailed Description
Deceased organ donors are maintained on life support including mechanical ventilation during the time between brain death and organ procurement. The optimal mode of mechanical ventilation for deceased...
Eligibility Criteria
Inclusion
- Brain death
- Authorization for research
- ≥13 years of age
Exclusion
- Arterial/Inspired oxygen ratio (PaO2/FiO2) ≤ 150 mmHg
- PaO2/FiO2 ≥ 400 mmHg
- BMI \> 40
- Hepatitis B surface antigen positive
- Hepatitis C positive
- Failure to complete donation process
- Hemodynamic instability
Key Trial Info
Start Date :
July 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2021
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT03439995
Start Date
July 9 2018
End Date
January 1 2021
Last Update
May 6 2021
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA
Los Angeles, California, United States, 90095
2
Stanford University
Palo Alto, California, United States, 94305
3
University of California San Francisco
San Francisco, California, United States, 94143
4
Donor Network West
San Ramon, California, United States, 94583